TY  - GEN
AU  - Kaymakcalan,Marina D
AU  - Xie,Wanling
AU  - Albiges,Laurence
AU  - North,Scott A
AU  - Kollmannsberger,Christian K
AU  - Smoragiewicz,Martin
AU  - Kroeger,Nils
AU  - Wells,J Connor
AU  - Rha,Sun-Young
AU  - Lee,Jae Lyun
AU  - McKay,Rana R
AU  - Fay,André P
AU  - De Velasco,Guillermo
AU  - Heng,Daniel Y C
AU  - Choueiri,Toni K
TI  - Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
SN  - 1097-0142
PY  - 2016///0707
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Axitinib
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - blood
KW  - Databases, Factual
KW  - Diarrhea
KW  - chemically induced
KW  - Drug Administration Schedule
KW  - Fatigue
KW  - Female
KW  - Hand-Foot Syndrome
KW  - etiology
KW  - Humans
KW  - Imidazoles
KW  - Indazoles
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Models, Statistical
KW  - Molecular Targeted Therapy
KW  - adverse effects
KW  - Mucositis
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Predictive Value of Tests
KW  - Pyrimidines
KW  - Pyrroles
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sorafenib
KW  - Sulfonamides
KW  - Sunitinib
KW  - Vascular Endothelial Growth Factor A
KW  - drug effects
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.29773
ER  -